Standard BioTools Inc.

NASDAQ: FLDM · Real-Time Price · USD
3.71
-0.28 (-7.02%)
At close: Apr 06, 2022, 6:00 AM

Standard BioTools Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
124.29M 130.58M 136.92M 148.28M 143.32M
Cost of Revenue
61.72M 61.21M 61.58M 61.28M 57.41M
Gross Profit
62.57M 69.37M 75.35M 87M 85.92M
Operating Income
-121.88M -65.37M -73.1M -58.96M -55.41M
Interest Income
n/a n/a n/a n/a n/a
Pretax Income
-120.03M -63.66M -70.46M -61.43M -57.93M
Net Income
-116.7M -59.24M -67.83M -59.99M -55.86M
Selling & General & Admin
102.16M 98.89M 107.86M 106.45M 102.81M
Research & Development
36.06M 37.94M 40.59M 39.51M 38.52M
Other Expenses
n/a n/a n/a n/a n/a
Operating Expenses
138.21M 136.83M 148.45M 145.95M 141.33M
Interest Expense
3.97M 3.82M 3.64M 3.56M 3.56M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a
Cost & Expenses
199.93M 198.04M 210.03M 207.24M 198.74M
Income Tax Expense
-3.33M -4.42M -2.62M -1.44M -2.07M
Shares Outstanding (Basic)
77.03M 76.65M 76.3M 75.45M 74.71M
Shares Outstanding (Diluted)
77.03M 76.65M 76.3M 75.45M 74.71M
EPS (Basic)
-1.52 -0.78 -0.9 -0.8 -0.75
EPS (Diluted)
-1.52 -0.78 -0.9 -0.8 -0.75
EBITDA
-100.44M -44.27M -52.98M -43.42M -38.59M
EBIT
-116.06M -59.84M -66.81M -57.88M -54.37M
Depreciation & Amortization
15.63M 15.57M 13.83M 14.46M 15.78M